UK Aquaculture Vaccines Market Insight
Published: 23 May 2026 | Report Format: Electronic (PDF)
The UK aquaculture vaccines market size is rapidly expanding, at about a 13.44% CAGR, and the sustainable fish farming, seafood demand, disease prevention, and advanced veterinary biotechnology adoption.
UK Aquaculture Vaccines Market Insights Forecasts to 2035
- The UK Aquaculture Vaccines Market Size Was Estimated at USD 452.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 13.44% from 2025 to 2035
- The UK Aquaculture Vaccines Market Size is Expected to Reach USD 1597.2 Million by 2035
Notable Insights into the United Kingdom Aquaculture Vaccines Market
- Injectable fish vaccines kind of take about 49% of the UK aquaculture vaccines market mostly because salmon farming is going strong, plus the whole long-term immunity angle really helps, and then bacterial disease control too, also the biosecurity and aquaculture health investments exceeding GBP 120Million seem to be pushing productivity.
- Salmon aquaculture, meanwhile, holds nearly 44% share. That share is supported by rising production and export demand, and the GBP 200Million sustainable fish farming investments, which are enhancing disease resistant systems, efficiency, and this broader marine biotechnology development moving across UK operations.
Download the eBook (ToC)
- The UK seafood and aquaculture industry contributes more than USD 6 billion each year, which feeds economic growth and fish health management, disease prevention, and sustainable marine production, and it looks tied to GBP 300Million biotechnology investments that strengthen resilience overall.
- The UK government has allocated around USD 150 million between 2024–2026 for aquaculture, marine biotechnology, aquatic animal health, and supply chain modernization. That should improve productivity, sustainability, and advanced seafood innovation ecosystems, across national waters.
Research Methodologies Used to Analyze the United Kingdom Aquaculture Vaccines Market
The UK aquaculture vaccines market is created using primary and secondary market research techniques that help in generating precise market data and veterinary biotechnology information. Around 72% of the market research is based on secondary research from government aquaculture publications, veterinary health resources, seafood industry reports, annual reports of companies, and marine biotechnology journals; whereas around 28% is based on primary research interviews conducted with fish producers, marine veterinarians, fish vaccines manufacturers, marine biologists, seafood processing firms, and regulatory agencies.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK aquaculture vaccines market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Aquaculture Vaccines Market
- Zoetis Inc.
- Elanco Animal Health
- MSD Animal Health
- HIPRA
- Phibro Animal Health Corporation
- Benchmark Holdings plc
- AquaGen AS
- Virbac Group
- Others
Recent Developments:
- In February 2026, Benchmark Holdings plc advanced aquaculture health solutions in the United Kingdom, supporting GBP 180Million biotech investments, improving salmon farming productivity, sea lice control, vaccine innovation, and sustainable marine aquaculture growth.
- In October 2025, MSD Animal Health strengthened aquaculture vaccine solutions in the United Kingdom, supporting USD 2.5Billion biotech investments, improving bacterial disease prevention, immune response efficiency, salmon farming productivity, and sustainable aquaculture growth.
Market Segmentation:
United Kingdom Aquaculture Vaccines Market, By Vaccine Type
- Injectable Vaccines
- Oral Vaccines
- Immersion Vaccines
United Kingdom Aquaculture Vaccines Market, By Species
- Salmon
- Trout
- Tilapia
- Carp
- Shrimp
- Others
United Kingdom Aquaculture Vaccines Market, By Disease Type
- Bacterial Diseases
- Viral Diseases
- Parasitic Diseases
- Fungal Diseases
United Kingdom Aquaculture Vaccines Market, By End User
- Commercial Fish Farms
- Hatcheries
- Aquatic Veterinary Clinics
- Aquaculture Research Institutes
- Others
Expert Views:
The UK aquaculture vaccines market is expected to experience steady growth in the long run owing to the rising consumption of seafood, growing preference for an antibiotic-free aquaculture process, and growth in fish health care technology. The government's initiatives for promoting sustainable production, innovations in aquatic biotechnology, and disease-prevention programs would help boost the market further.
Author: Govind and Krishna By Spherical Insights and Consulting